Therapeutic Asset Ratings

705 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
ft538 Neoplasm	Masonic Cancer Center, University of Minnesota	P1	D (24)
Mgta-456 Relapsed/Refractory Diffuse Large B-Cell Lymphoma	Masonic Cancer Center, University of Minnesota	P2	NR (0)
Gtb-5550 Tri-specific Killer Engager	Masonic Cancer Center, University of Minnesota	P1	NR (0)
RGDCRAdCOX2F Pancreatic Adenocarcinoma	Masonic Cancer Center, University of Minnesota	P1	NR (0)
92.3% TO NMT 93.8% ETHANOL BY WEIGHT IN WATER Carcinoma	Masonic Cancer Center, University of Minnesota	N/A	NR (0)

Showing 701 to 705 of 705 assets

PreviousPage 29 of 29Next